Overview

A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients

Status:
Completed
Trial end date:
2018-12-04
Target enrollment:
Participant gender:
Summary
To investigate the safety of C13-CAC and the relationship among C13-CAC breath test, gastric pH, and the improvement of symptoms by switching PPI in PPI resistant GERD patients
Phase:
Phase 2
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Calcium